CAS 40180-80-1
:1-(3-brom-4-methylphenyl)ethanon
- Ethanone, 1-(3-Bromo-4-Methylphenyl)-
- 1-(3-Bromo-4-methylphenyl)ethanone
- 3'-BROMO-4'-METHYLACETOPHENONE ISO 9001:2015 REACH
- 1-(3-Bromo-4-methylphenyl)ethan-1-one
- SIPO-022
- 3'-BROMO-4'-METHYLACETOPHENONE
- Fluralaner-004
- 3'-Bromo-4'-methylacetophenone 97%
- Siponimod Impurity 1
3'-Bromo-4'-methylacetophenone
CAS:Formel:C9H9BrOReinheit:>98.0%(GC)Farbe und Form:White to Light yellow powder to crystalMolekulargewicht:213.071-(3-Bromo-4-methylphenyl)ethanone
CAS:Formel:C9H9BrOReinheit:97%Farbe und Form:SolidMolekulargewicht:213.07123-Bromo-4-methylacetophenone
CAS:3-Bromo-4-methylacetophenoneReinheit:99%Molekulargewicht:213.07g/mol3'-Bromo-4'-methylacetophenone
CAS:3'-Bromo-4'-methylacetophenone is a reactive methyl ester that binds to the receptor in the central nervous system. It has been found to be an effective anti-cancer drug, and also inhibits serotonin release in the brain. 3'-Bromo-4'-methylacetophenone is chiral, meaning it can exist as two different forms, or enantiomers. These two forms have different pharmacological profiles, with one being more potent than the other. 3'-Bromo-4'-methylacetophenone is synthesized from methylamine and acetaldehyde using diethyl ether as a solvent. The reaction product is then hydrolyzed by acetonitrile to produce the final product. This drug is used for the treatment of Parkinson's disease and schizophrenia.
Formel:C9H9BrOReinheit:Min. 95%Farbe und Form:PowderMolekulargewicht:213.07 g/mol1-(3-Bromo-4-methylphenyl)ethanone
CAS:Formel:C9H9BrOReinheit:95%Farbe und Form:SolidMolekulargewicht:213.0743'-Bromo-4'-methylacetophenone
CAS:Kontrolliertes ProduktApplications 3'-Bromo-4'-methylacetophenone is used as a starting material in the synthesis of mansonone E which is used to make mansonone E dervivatives. These derivatives are potent inhibitors of topoisomerase II (Topo II) and topoisomerase I (Topo I) and are also potent antitumor agents. 3'-Bromo-4'-methylacetophenone is also used as a reagent in the synthesis of BAF312, Siponimod which has been tested in the treatment of patients suffering from relapsing-remitting multiple sclerosis.
References Fang, X., et al.: J. Chem. Res., 38, 137 (2014); Huang, Z., et al.: Eur. J. Med. Chem., 68, 58 (2013); Pan, S., et al.: ACS Med. Chem. Lett., 4, 333 (2013)Formel:C9H9BrOFarbe und Form:NeatMolekulargewicht:213.07





